Abstract:Infection is the most prevalent complication of fractures, particularly in open fractures, and often leads to severe consequences. The emergence of bacterial resistance has significantly exacerbated the burden of infection in clinical practice, making infection control a significant treatment challenge for infectious bone defects. The implantation of a structural stent is necessary to treat large bone defects despite the increased risk of infection. Therefore, there is a need for the development of novel antibacterial therapies. The advancement in antibacterial biomaterials and new antimicrobial drugs offers fresh perspectives on antibacterial treatment. Although antimicrobial 3D scaffolds are currently under intense research focus, relying solely on material properties or antibiotic action remains insufficient. Antimicrobial peptides (AMPs) are one of the most promising new antibacterial therapy approaches. This review discusses the underlying mechanisms behind infectious bone defects and presents research findings on antimicrobial peptides, specifically emphasizing their mechanisms and optimization strategies. We also explore the potential prospects of utilizing antimicrobial peptides in treating infectious bone defects. Furthermore, we propose that Artificial intelligence (AI) algorithms can be utilized for predicting the pharmacokinetic properties of AMPs, including absorption, distribution, metabolism, and excretion, and by combining information from genomics, proteomics, metabolomics, and clinical studies with computational models driven by machine learning algorithms, scientists can gain a comprehensive understanding of AMPs' mechanisms of action, therapeutic potential, and optimizing treatment strategies tailored to individual patients, and through interdisciplinary collaborations between computer scientists, biologists, and clinicians, the full potential of AI in accelerating the discovery and development of novel AMPs will be realized. Besides, with the continuous advancements in 3D/4D/5D/6D technology and its integration into bone scaffold materials, we anticipate remarkable progress in the field of regenerative medicine.

Antibacterial peptides-loaded bioactive materials for the treatment of bone infection

Extracellular Matrix Scaffold Crosslinked with Vancomycin for Multifunctional Antibacterial Bone Infection Therapy

Functional Antimicrobial Peptide-loaded 3D Scaffolds for Infected Bone Defect Treatment with AI and Multidimensional Printing

Implantable biomedical materials for treatment of bone infection

Implantable antimicrobial biomaterials for local drug delivery in bone infection models

Development of an antimicrobial peptide-loaded mineralized collagen bone scaffold for infective bone defect repair

Shaping the Future of Antimicrobial Therapy: Harnessing the Power of Antimicrobial Peptides in Biomedical Applications

BMP4 Peptide and Enoxacin-Loaded Mesoporous Silica Nanoparticles Direct Cell Fate and Boost Bone Regeneration During Infection

Dual-functional composite scaffolds for inhibiting infection and promoting bone regeneration

Advances in Copper-Based Biomaterials With Antibacterial and Osteogenic Properties for Bone Tissue Engineering

Bone infection site targeting nanoparticle-antibiotics delivery vehicle to enhance treatment efficacy of orthopedic implant related infection

Antimicrobial Peptides-Loaded Hydroxyapatite Microsphere With Different Hierarchical Structures for Enhanced Drug Loading, Sustained Release and Antibacterial Activity

Dealing with MDR bacteria and biofilm in the post-antibiotic era: Application of antimicrobial peptides-based nano-formulation

Design of functional vancomycin-embedded bio-derived extracellular matrix hydrogels for repairing infectious bone defects

Sustained Release of Antimicrobial Peptide from Self-assembling Hydrogel Enhanced Osteogenesis.

Bioactive mesoporous silica nanoparticle-functionalized titanium implants with controllable antimicrobial peptide release potentiate the regulation of inflammation and osseointegration

Advances in reparative materials for infectious bone defects and their applications in maxillofacial regions

Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and future prospects

Self-assembling peptide hydrogel scaffold integrating stem cell-derived exosomes for infected bone defects

Engineering Approaches for the Development of Antimicrobial Peptide-Based Antibiotics

Chitosan-Based Biomaterial Scaffolds for the Repair of Infected Bone Defects